Andrew Pain

1PUBLICATIONS
0CO-AUTHORS
Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 20, 2025
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease.

Stephen Salloway, Andrew Pain, Elly Lee

Pageof 1

Frequent Collaborators